Bryn Mawr Trust CO Teva Pharmaceutical Industries LTD Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bryn Mawr Trust CO holds 2,759 shares of TEVA stock, worth $56,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,759
Previous 39,573
93.03%
Holding current value
$56,504
Previous $663,000
91.7%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
659Shares Held
667MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$880 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$788 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$785 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$774 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$773 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $22.7B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...